Search | Page 30 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Randomized Allogeneic Azacitidine Study

    ... with AML, CMML, or MDS after an allogeneic (donor) stem cell transplant . The safety of this drug will also be studied. ...

    Clinical Trial last updated 05/03/2016 - 11:08am.

  2. A Phase II Study of 5-Azacitidine and Sargramostim as Maintenance Treatment After Definitive Therapy for Poor-risk AML or MDS

    ... are in remission after definitive treatment with either stem cell transplant or cytarabine-based consolidation chemotherapy . ...

    Clinical Trial last updated 05/03/2016 - 10:38am.

  3. Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS

    ... of two novel conditioning therapies for hematopoietic stem cell transplant (HSCT). The primary focus of both the investigators' ...

    Clinical Trial last updated 05/03/2016 - 10:36am.

  4. Hildegard Greinix, MD

    ... Government to the European Commission's directives on stem cells and tissues and she has been an active participant of the NIH ... electronic access to all scientific journals, the stem cell transplant community has become an international network allowing ...

    Bio last updated 03/11/2016 - 1:41pm.

  5. Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

    ... of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). This study aims to determine if any of three new ...

    Clinical Trial last updated 06/06/2016 - 1:59pm.

  6. Telomere Length and Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia

    ... Telomere length in hematopoietic stem cell transplantation for severe aplastic anemia: is it ready for "prime time"? ...

    Research Review last updated 05/02/2016 - 9:13am.

  7. Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

    ... of an unacceptable toxicity, or hematopoietic stem cell transplant (HSCT). Status:  ...

    Clinical Trial last updated 04/28/2016 - 4:16pm.

  8. A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)

    ... for potentially curative options such as allogeneic stem cell transplant . No chemotherapy or study drugs for >3 weeks prior to ...

    Clinical Trial last updated 06/03/2016 - 3:09pm.

  9. Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission (QUAZAR AML-001)

    ... of such translocations Prior bone marrow or stem cell transplantation Candidate for allogeneic bone marrow or stem cell ...

    Clinical Trial last updated 04/29/2016 - 8:39am.

  10. Graft-vs-host-disease (GVHD): Signs, Symptoms, and Treatment

    ... Webinar An allogeneic stem cell transplant uses blood-forming cells ( stem cells ) donated by ...

    LMS Item last updated 06/10/2016 - 1:24pm.